Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-16 7:15 pm Sale | 2026-06-12 | 13D | BIOMX INC PAR $0.0001 PHGE | Flynn James E | 533,370 4.700% | -356,558 (-40.07%) | Filing History |
| 2026-05-28 6:13 pm Sale | 2026-05-26 | 13D | BIOMX INC PAR $0.0001 PHGE | Flynn James E | 889,928 8.090% | -99,128 (-10.02%) | Filing History |
| 2026-05-14 8:22 pm Sale | 2026-05-14 | 13G | INSPIRE MED SYS INC INSP | Flynn James E | 1,296,862 4.500% | -179,441 (-12.15%) | Filing History |
| 2026-05-14 6:20 pm Sale | 2026-03-31 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 9,043,903 5.290% | -9,215 (-0.10%) | Filing History |
| 2026-05-14 6:20 pm Purchase | 2026-03-31 | 13G | FOGHORN THERAPEUTICS INC FHTX | Flynn James E | 5,139,523 8.640% | 2,204,228 (+75.09%) | Filing History |
| 2026-04-15 5:37 pm Unchanged | 2026-04-15 | 13D | BIOMX INC PAR $0.0001 PHGE | Flynn James E | 989,056 9.990% | 0 (Unchanged) | Filing History |
| 2026-03-02 7:46 pm Purchase | 2026-02-27 | 13D | LARIMAR THERAPEUTICS INC LRMR | Flynn James E | 35,667,474 34.410% | 5,000,000 (+16.30%) | Filing History |
| 2026-02-12 2:17 pm Purchase | 2025-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Flynn James E | 14,341,000 6.810% | 2,172,000 (+17.85%) | Filing History |
| 2026-02-12 2:16 pm Sale | 2025-12-31 | 13G | NUVALENT INC NUVL | Flynn James E | 22,852,280 24.210% | -729,998 (-3.10%) | Filing History |
| 2026-02-11 7:24 pm Purchase | 2026-02-09 | 13D | BIOMX INC PAR $0.0001 PHGE | Flynn James E | 989,056 9.990% | 170,190 (+20.78%) | Filing History |
| 2026-02-06 6:43 pm Sale | 2026-02-06 | 13G | CALCIMEDICA INC CALC | Flynn James E | 653,253 4.340% | -1,959,759 (-75.00%) | Filing History |
| 2025-11-25 3:36 pm Sale | 2025-11-25 | 13G | CERTARA INC CERT | Flynn James E | 7,808,605 4.900% | -2,202,395 (-22.00%) | Filing History |
| 2025-11-13 5:32 pm Purchase | 2025-11-07 | 13G | CERTARA INC CERT | Flynn James E | 10,011,000 6.290% | 10,011,000 (New Position) | Filing History |
| 2025-11-13 5:32 pm Purchase | 2025-11-06 | 13G | INSPIRE MED SYS INC INSP | Flynn James E | 1,476,303 5.080% | 1,476,303 (New Position) | Filing History |
| 2025-11-13 4:28 pm Sale | 2025-09-30 | 13G | CULLINAN THERAPEUTICS INC CGEM | Flynn James E | 2,927,013 4.950% | -356,811 (-10.87%) | Filing History |
| 2025-11-13 4:28 pm Unchanged | 2025-09-30 | 13G | Lomond Therapeutics Holdings, Inc. | Flynn James E | 2,692,625 8.360% | 0 (Unchanged) | Filing History |
| 2025-11-13 4:27 pm Sale | 2025-11-10 | 13G | INDIVIOR PLC USD0.5 INDV | Flynn James E | 4,614,498 3.700% | -5,952,662 (-56.33%) | Filing History |
| 2025-11-13 4:27 pm Sale | 2025-09-30 | 13G | OSCAR HEALTH INC OSCR | Flynn James E | 0 0.000% | -11,835,000 (Position Closed) | Filing History |
| 2025-11-13 4:26 pm Purchase | 2025-09-30 | 13G | ADAPTHEALTH CORP AHCO | Flynn James E | 23,863,685 8.480% | 105,292 (+0.44%) | Filing History |
| 2025-11-05 6:24 pm Purchase | 2025-10-30 | 13G | SAVARA INC SVRA | Flynn James E | 13,569,000 6.740% | 9,634,001 (+244.83%) | Filing History |